Target Validation Information
TTD ID T27265
Target Name Oxo-5-alpha-steroid 4-dehydrogenase (SRD5A)
Type of Target
Successful
Drug Potency against Target Dutasteride Drug Info Ki = 4.3 nM [2]
Finasteride Drug Info Ki = 23 nM [2]
Dutasteride + tamsulosin Drug Info IC50 = 6 nM [1]
References
REF 1 Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line. Prostate. 2004 Feb 1;58(2):130-44.
REF 2 Pharmacogenetic analysis of human steroid 5 alpha reductase type II: comparison of finasteride and dutasteride. J Mol Endocrinol. 2005 Jun;34(3):617-23.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.